Population pharmacokinetic analysis of Datopotamab deruxtecan (Dato-DXd), a TROP2-targeting antibody-drug conjugate

PAGE 32 (2024) Abstr 10859
Peigné S, Pan Y, Friberg Hietala S, Mc Laughlin AM, Tajima N, Uema D, Zebger-Gong H, Tang Z, Zhou D, Garimella T, Abutarif M, Hong Y.
ConferenceOncologyPharmacometricsTrial design and analysis

Pharmetheus Affiliates

Portrait-of-Sophie-Peigne-Pharmetheus-1
Senior Director, MIDD Consultant

Sophie Peigné

See bio
Portrait-of-Sofia-Friberg-Hietala_Pharmetheus
Principal Director, Client Operations Manager

Sofia Friberg Hietala

See bio
Portrait-of-Anna-Mc-Laughlin_Pharmetheus
Senior Director, MIDD Consultant

Anna Mc Laughlin

See bio